Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» RSV
RSV
GSK’s Arexvy Leads Over Pfizer’s Abrysvo in Year One of RSV Vaccine Market Battle
Xtalks
Mon, 02/5/24 - 11:12 pm
GSK
Pfizer
RSV
Arexvy
Abrysvo
vaccines
Sanofi expects RSV antibody to breach blockbuster status in 2024, even as supply hitch drags on
Fierce Pharma
Thu, 02/1/24 - 11:33 am
Sanofi
RSV
AstraZeneca
Beyfortus
GSK confirms Arexvy is a blockbuster but says the RSV battle has just begun
Fierce Pharma
Wed, 01/31/24 - 11:49 am
GSK
Pfizer
RSV
vaccines
Arexvy
GSK RSV vaccine achieves blockbuster status in just over six months
Tip Ranks
Mon, 01/29/24 - 10:30 pm
GSK
RSV
vaccines
Arexvy
Pfizer
AZ, Sanofi’s Beyfortus cleared in China for RSV prevention
Pharmaphorum
Tue, 01/2/24 - 10:09 am
AstraZeneca
Sanofi
Beyfortus
RSV
vaccines
China
AstraZeneca, Sanofi to supply 230,000 more RSV infant shots to US market
Reuters
Thu, 12/14/23 - 10:48 pm
RSV
vaccines
Sanofi
AstraZeneca
AstraZeneca Buys into RSV Vaccine Market with Potential $1.1B Icosavax Purchase
BioSpace
Tue, 12/12/23 - 11:17 am
AstraZeneca
Icosavax
RSV
M&A
vaccines
GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster Status
BioSpace
Fri, 12/1/23 - 11:30 am
GSK
Pfizer
RSV
vaccines
Arexvy
GSK CEO says RSV vaccine revenue to top 1 bln pounds in first year
Reuters
Thu, 11/30/23 - 11:12 pm
GSK
RSV
vaccines
Emma Walmsley
Pharma CEOs
Senate Democrats press Sanofi and AZ for answers as 'unprecedented' demand spurs shortage of RSV antibody Beyfortus
Fierce Pharma
Mon, 11/20/23 - 09:38 pm
Sanofi
AstraZeneca
Senate
CDC
RSV
Beyfortus
drug shortages
RSV is on the rise but preventative drugs are in short supply
MIT Technology Review
Mon, 11/6/23 - 10:04 am
RSV
CDC
vaccines
nirsevimab
drug shortages
AstraZeneca
GSK outpaces Pfizer in RSV vaccine market
BioPharma Dive
Wed, 11/1/23 - 11:19 am
GSK
Pfizer
vaccines
RSV
Arexvy
Abrysvo
Pfizer RSV vaccine gets off to fast start on market
BioPharma Dive
Tue, 10/31/23 - 09:21 pm
Pfizer
RSV
vaccines
Abrysvo
GSK targets younger age group with RSV vaccine Arexvy
Pharmaphorum
Wed, 10/25/23 - 09:43 am
GSK
RSV
Arexvy
vaccines
Widespread use of Pfizer's maternal RSV shot would reduce costs and prevent infant hospitalizations: study
Fierce Pharma
Wed, 10/11/23 - 11:52 pm
Pfizer
RSV
vaccines
pregnancy
infants
Inside Bavarian Nordic’s late-stage stumbles — and drive to become a vaccine giant
Pharma Voice
Wed, 09/27/23 - 10:10 am
Bavarian Nordic
vaccines
RSV
COVID-19
Paul Chaplin
CDC recommends RSV vaccine in late pregnancy to protect newborns
NPR
Sun, 09/24/23 - 08:53 pm
Pfizer
CDC
pregnancy
RSV
Abryvso
vaccines
New RSV vaccines can be powerful tools, but rollout poses test
BioPharma Dive
Mon, 09/18/23 - 09:59 am
vaccines
RSV
Vaccine experts urge more inclusivity in clinical trials
Stat
Wed, 09/6/23 - 09:49 am
vaccines
RSV
clinical trials
inclusivity
Abrysvo and Beyfortus Could Transform RSV Prophylaxis for Young Children in the US
Clinical Trials Arena
Tue, 08/29/23 - 11:23 am
Pfizer
AstraZeneca
Sanofi
Abrysvo
Beyfortus
RSV
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »